Deborah Rotenstein

643 total citations
28 papers, 446 citations indexed

About

Deborah Rotenstein is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Deborah Rotenstein has authored 28 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 10 papers in Molecular Biology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Deborah Rotenstein's work include Spinal Dysraphism and Malformations (9 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Sexual Differentiation and Disorders (4 papers). Deborah Rotenstein is often cited by papers focused on Spinal Dysraphism and Malformations (9 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Sexual Differentiation and Disorders (4 papers). Deborah Rotenstein collaborates with scholars based in United States and Australia. Deborah Rotenstein's co-authors include Donald H. Reigel, Lorah D. Dorn, Bhagirath Majmudar, Lisa Dorn, Timothy J. Breen, Margaret Adams, Lynda L. Flom, Angela Lotsikas, Susan M. Sereika and Giovanni Cizza and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Deborah Rotenstein

28 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Rotenstein United States 13 164 98 91 88 86 28 446
Kiyoshi Uchide Japan 14 77 0.5× 62 0.6× 64 0.7× 22 0.3× 42 0.5× 34 458
Gianni Bocca Netherlands 15 197 1.2× 67 0.7× 124 1.4× 75 0.9× 85 1.0× 38 581
Menelaos L. Batrinos Greece 13 105 0.6× 32 0.3× 37 0.4× 217 2.5× 86 1.0× 47 522
R Jewelewicz United States 12 180 1.1× 60 0.6× 72 0.8× 92 1.0× 30 0.3× 29 521
Nathan A. Jacobson United States 14 57 0.3× 117 1.2× 30 0.3× 34 0.4× 30 0.3× 27 424
Nehama Zuckerman‐Levin Israel 16 72 0.4× 71 0.7× 73 0.8× 250 2.8× 193 2.2× 37 620
S. Goldstein United States 9 91 0.6× 23 0.2× 22 0.2× 123 1.4× 26 0.3× 10 453
Helmut Pschera Sweden 12 72 0.4× 80 0.8× 151 1.7× 55 0.6× 55 0.6× 38 515
Samuel H. Wood United States 11 308 1.9× 35 0.4× 22 0.2× 53 0.6× 195 2.3× 37 617
Courtney Marsh United States 15 140 0.9× 40 0.4× 100 1.1× 65 0.7× 238 2.8× 40 693

Countries citing papers authored by Deborah Rotenstein

Since Specialization
Citations

This map shows the geographic impact of Deborah Rotenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Rotenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Rotenstein more than expected).

Fields of papers citing papers by Deborah Rotenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Rotenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Rotenstein. The network helps show where Deborah Rotenstein may publish in the future.

Co-authorship network of co-authors of Deborah Rotenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Rotenstein. A scholar is included among the top collaborators of Deborah Rotenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Rotenstein. Deborah Rotenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Miller, Bradley S., Deborah Rotenstein, Larry C. Deeb, John Germak, & Tami Wisniewski. (2014). Persistence with growth hormone therapy in pediatric patients. The American Journal of Managed Care. 6(1). 5 indexed citations
3.
Tissot, Abbigail M., Lisa Dorn, Deborah Rotenstein, et al.. (2011). Neuropsychological Functioning in Girls with Premature Adrenarche. Journal of the International Neuropsychological Society. 18(1). 151–156. 10 indexed citations
4.
Fuqua, John S., Deborah Rotenstein, & Peter A. Lee. (2010). Duration of Suppression of Adrenal Steroids after Glucocorticoid Administration. International Journal of Pediatric Endocrinology. 2010. 1–8. 15 indexed citations
5.
Rotenstein, Deborah, et al.. (2010). Duration of Suppression of Adrenal Steroids after Glucocorticoid Administration. International Journal of Pediatric Endocrinology. 2010(1). 712549–712549. 9 indexed citations
6.
Dorn, Lisa, Susan R. Rose, Deborah Rotenstein, et al.. (2008). Differences in Endocrine Parameters and Psychopathology in Girls with Premature Adrenarche versus On-time Adrenarche. Journal of Pediatric Endocrinology and Metabolism. 21(5). 439–48. 38 indexed citations
7.
Rotenstein, Deborah, et al.. (2008). Treatment of Precocious Puberty in a Female with Prader-Willi Syndrome. Journal of Pediatric Endocrinology and Metabolism. 21(5). 495–500. 13 indexed citations
8.
Rotenstein, Deborah, et al.. (2004). Treatment to Near Adult Stature of Patients with Myelomeningocele with Recombinant Human Growth Hormone. Journal of Pediatric Endocrinology and Metabolism. 17(9). 1195–200. 6 indexed citations
9.
Dorn, Lorah D. & Deborah Rotenstein. (2004). Early puberty in girls: The case of premature adrenarche. Women s Health Issues. 14(6). 177–183. 10 indexed citations
10.
Cizza, Giovanni, et al.. (2001). Circulating Plasma Leptin and IGF-1 Levels in Girls with Premature Adrenarche: Potential Implications of a Preliminary Study. Hormone and Metabolic Research. 33(3). 138–143. 34 indexed citations
11.
Dorn, Lorah D., et al.. (1999). Biopsychological and Cognitive Differences in Children With Premature vs On-Time Adrenarche. Archives of Pediatrics and Adolescent Medicine. 153(2). 137–46. 55 indexed citations
12.
Rotenstein, Deborah & Donald H. Reigel. (1998). The Endocrine Control of Growth for Patients with Myelomeningocele. The Endocrinologist. 8(4). 260–264. 2 indexed citations
13.
Rotenstein, Deborah, Donald H. Reigel, & Joseph F. Lucke. (1996). Growth of Growth Hormone-Treated and Nontreated Children before and after Tethered Spinal Cord Release. Pediatric Neurosurgery. 24(5). 237–241. 13 indexed citations
14.
Rotenstein, Deborah & Donald H. Reigel. (1996). Growth hormone treatment of children with neural tube defects: Results from 6 months to 6 years. The Journal of Pediatrics. 128(2). 184–189. 15 indexed citations
15.
Rotenstein, Deborah & Timothy J. Breen. (1996). Growth hormone treatment of children with myelomeningocele. The Journal of Pediatrics. 128(5). S28–S31. 17 indexed citations
16.
Rotenstein, Deborah, Margaret Adams, & Donald H. Reigel. (1995). Adult stature and anthropomorphic measurements of patients with myelomeningocele. European Journal of Pediatrics. 154(5). 398–402. 26 indexed citations
17.
Reigel, Donald H., et al.. (1994). Change in Spinal Curvature following Release of Tethered Spinal Cord Associated with Spina bif ida. Pediatric Neurosurgery. 20(1). 30–42. 52 indexed citations
18.
Rotenstein, Deborah, Donald H. Reigel, & Lynda L. Flom. (1989). Growth hormone treatment accelerates growth of short children with neural tube defects. The Journal of Pediatrics. 115(3). 417–420. 24 indexed citations
19.
Wolfson, Adele J., et al.. (1985). Binding of activated progesterone receptor to microsomes. Journal of Steroid Biochemistry. 22(6). 721–726. 2 indexed citations
20.
Blatt, Julie, et al.. (1984). Cytotoxicity of tamoxifen for acute lymphoblastic leukaemia in vitro. British Journal of Cancer. 50(6). 837–839. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026